FR2364922A1 - Sel solide de la cephalosporine et procede pour le preparer - Google Patents

Sel solide de la cephalosporine et procede pour le preparer

Info

Publication number
FR2364922A1
FR2364922A1 FR7726357A FR7726357A FR2364922A1 FR 2364922 A1 FR2364922 A1 FR 2364922A1 FR 7726357 A FR7726357 A FR 7726357A FR 7726357 A FR7726357 A FR 7726357A FR 2364922 A1 FR2364922 A1 FR 2364922A1
Authority
FR
France
Prior art keywords
cephalosporin
preparing
solid salt
salt
solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7726357A
Other languages
English (en)
Other versions
FR2364922B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FR2364922A1 publication Critical patent/FR2364922A1/fr
Application granted granted Critical
Publication of FR2364922B1 publication Critical patent/FR2364922B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Sel solide de la céphalosporine et procédé pour le préparer. Ce dérivé qui a la formule :
FR7726357A 1976-08-31 1977-08-30 Sel solide de la cephalosporine et procede pour le preparer Granted FR2364922A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51104583A JPS603314B2 (ja) 1976-08-31 1976-08-31 セフアロスポリン誘導体およびその製造法

Publications (2)

Publication Number Publication Date
FR2364922A1 true FR2364922A1 (fr) 1978-04-14
FR2364922B1 FR2364922B1 (fr) 1981-07-31

Family

ID=14384446

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7726357A Granted FR2364922A1 (fr) 1976-08-31 1977-08-30 Sel solide de la cephalosporine et procede pour le preparer

Country Status (15)

Country Link
US (1) US4146710A (fr)
JP (1) JPS603314B2 (fr)
BE (1) BE858296A (fr)
BG (1) BG60439B2 (fr)
CA (1) CA1102310A (fr)
CH (1) CH630088A5 (fr)
DE (1) DE2738711C2 (fr)
DK (1) DK151340C (fr)
FR (1) FR2364922A1 (fr)
GB (1) GB1589841A (fr)
HK (1) HK27784A (fr)
MY (1) MY8500266A (fr)
NL (1) NL189355C (fr)
NO (1) NO154015C (fr)
SE (1) SE426069B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1575803A (en) * 1976-03-09 1980-10-01 Fujisawa Pharmaceutical Co 3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof
US4189479A (en) * 1977-12-22 1980-02-19 Takeda Chemical Industries, Ltd. Cephalosporin esters
US4180658A (en) * 1978-02-24 1979-12-25 Bristol-Myers Company 7[-2-Alkoxyamino(acetamido)]cephalosporin derivatives
JPS5579393A (en) * 1978-12-11 1980-06-14 Takeda Chem Ind Ltd Cephalosporin derivative and its preparation
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
JPS58189186A (ja) * 1982-04-30 1983-11-04 Takeda Chem Ind Ltd セフアロスポリン誘導体
JPS63266177A (ja) * 1987-04-22 1988-11-02 Toyota Autom Loom Works Ltd 揺動斜板型圧縮機におけるコンロツドの連結方法
JPH06122630A (ja) * 1992-10-12 1994-05-06 Taiyo Yakuhin Kogyo Kk 安定な塩酸セフォチアム製剤
GB9503717D0 (en) * 1995-02-24 1995-04-12 Smithkline Beecham Plc Novel compounds
CN103601737B (zh) * 2013-12-04 2016-02-03 哈药集团制药总厂 一种盐酸头孢替安的制备方法
CN104926835B (zh) * 2015-06-24 2017-10-03 山东罗欣药业集团股份有限公司 一种盐酸头孢替安化合物、其制备方法及其药物组合物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2255077A1 (fr) * 1973-12-25 1975-07-18 Takeda Chemical Industries Ltd

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5119765A (en) * 1974-08-09 1976-02-17 Takeda Chemical Industries Ltd Aminochiazoorujudotaino seizoho

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2255077A1 (fr) * 1973-12-25 1975-07-18 Takeda Chemical Industries Ltd

Also Published As

Publication number Publication date
DK385777A (da) 1978-03-01
DE2738711C2 (de) 1985-07-11
JPS603314B2 (ja) 1985-01-26
DE2738711A1 (de) 1978-03-02
DK151340C (da) 1988-04-25
US4146710A (en) 1979-03-27
NO772960L (no) 1978-03-01
CH630088A5 (de) 1982-05-28
JPS5329913A (en) 1978-03-20
BG60439B2 (bg) 1995-03-31
NL7709614A (nl) 1978-03-02
HK27784A (en) 1984-03-30
GB1589841A (en) 1981-05-20
BE858296A (fr) 1978-02-28
FR2364922B1 (fr) 1981-07-31
SE7709745L (sv) 1978-03-01
SE426069B (sv) 1982-12-06
MY8500266A (en) 1985-12-31
NL189355C (nl) 1993-03-16
DK151340B (da) 1987-11-23
NO154015B (no) 1986-03-24
CA1102310A (fr) 1981-06-02
NO154015C (no) 1986-07-02
NL189355B (nl) 1992-10-16

Similar Documents

Publication Publication Date Title
FR2377989A1 (fr) Procede de preparation des trimethylolalcanes
RO76054A (fr) Procede pour la preparation des tetradecapeptides
RO74888A (fr) Procede pour la preparation des 4-acyleaminophenylethanolamines
FR2364922A1 (fr) Sel solide de la cephalosporine et procede pour le preparer
LU80224A1 (fr) Procede pour preparer des furocoumarines
RO75870A (fr) Procede pour la preparation des alkylendiamines
RO79398A (fr) Procede pour la preparation des 1-oxa-dethiacephalosporines
FR2361897A1 (fr) Nouveaux derives de la cephalosporine, leurs intermediaires et procede pour les preparer
RO71900A (fr) Procede pour preparer 1l-desoxy-16-aryle-omega-tetranorprostaglandine
FR2336359A1 (fr) Procede pour preparer des elements de construction revetus
RO83446A (fr) Procede pour la preparation des cyclopropylmethoxyanilides
BE849598A (fr) Procede pour preparer des organosiloxannes
FR2298548A1 (fr) Procede pour preparer des 2-amino-benzothiazoles
RO75980A (fr) Procede pour preparer 2beta-methylpyperazino-16-beta-pyperidino-3alpha-17beta-diacetoxy-5alpha-androstane
RO79264A (fr) Procede pour la preparation des derives de oleandomicine
BE875161A (fr) Procede pour preparer des monocaryons par dedicaryotisation de souches dicaryotiques de souches dicaryotiques de basidiomcetes
PT65681A (fr) Procede pour preparer des herbicides de pyrazolyl-triazol
FR2356658A1 (fr) Procede de production d'acides phosphinico-carboxyliques aliphatiques substitues
FR2381768A1 (fr) Procede pour preparer des composes chromeno-indole
FR2367047A1 (fr) Procede pour preparer des alpha-oxoesters
PT65877B (fr) Procede pour la preparation des composes heterocycliques
RO75074A (fr) Procede pour la preparation des thiophenoles
RO74147A (fr) Procede pour la preparation des triazolothienodiazepin-1-ones
RO81525A (fr) Procede pour la preparation des 9-fluor-prednisolones
FR2300770A1 (fr) Procede pour preparer des n,n-bis-(hydroxy-2 alkyl)-aminomethanephosphonates de dialkyle